LOKELMA 5 g, powder for oral suspension 30 sachets
Active ingredients: CYCLOSILICATE DE ZIRCONIUM SODIQUE
Commercialized according to BDPMDispensing in France: Prescription only
Powder for oral suspension30 sachetsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- LOKELMA 5 g, poudre pour suspension buvable
- Pharmaceutical form
- poudre pour suspension buvable
- Route of administration
- orale
- Presentation description
- 30 sachet(s) polytéréphtalate (PET) PEBDL : polyéthylène à basse densité linéaire aluminium
- Marketing authorisation holder
- ASTRAZENECA AB
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 17 Feb 2026
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
64737437CIP73014807CIP133400930148075Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CYCLOSILICATE DE ZIRCONIUM SODIQUEpoudre | 5 g · un sachet | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.